This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

CareFirst moves for class certification in US case against J&J over Stelara

( April 30, 2025, 22:31 GMT | Official Statement) -- MLex Summary: CareFirst asked a US federal judge to certify two proposed classes of third-party payers in a case accusing Johnson & Johnson of unlawfully delaying the introduction of biosimilar competition for Stelara, a treatment for autoimmune diseases. If approved, the classes would include all third-party payers who indirectly purchased or paid for, as part of a prescription drug benefit, some or all of the purchase price for personal use by their members, enrollees or beneficiaries from January 2024 to December 2025.See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections